ICD-10-CM Billable Code

M08.43

Pauciarticular juvenile rheumatoid arthritis, wrist

Clinical Classification Guidelines

Medical Intelligence & Overview

Pauciarticular juvenile rheumatoid arthritis (JRA), also known as oligoarticular JRA, is a form of juvenile arthritis that primarily affects a small number of joints. When this condition involves the wrist, it can impact a child's mobility and daily activities. This type of juvenile rheumatoid arthritis is characterized by inflammation that typically involves four or fewer joints, with the wrist being a common site of involvement. Recognizing the symptoms early and understanding the underlying causes can aid in managing this condition effectively.

Causes & Symptoms

Clinical Causes: Genetic predisposition: Children with a family history of autoimmune diseases may be more susceptible. Autoimmune response: The body's immune system mistakenly attacks the synovial membranes within the wrist joint. Environmental factors: Certain viral or bacterial infections might trigger immune responses that contribute to inflammation. Age and gender: Most commonly diagnosed in children under the age of 16, with a higher prevalence in girls.

Key Symptoms: Swelling in the wrist joint(s), often noticeable and persistent. Pain or tenderness during movement or when applying pressure to the wrist. Stiffness, especially after periods of inactivity, such as in the morning or after naps. Reduced range of motion in the affected wrist. Warmth and redness around the joint area. Possible swelling or involvement of nearby fingers or other small joints.

Diagnostic & Treatment

Diagnosis Path: Diagnosing pauciarticular juvenile rheumatoid arthritis of the wrist involves a combination of clinical evaluation and laboratory testing. Healthcare providers typically consider the child's medical history and conduct a physical examination focused on joint tenderness, swelling, and range of motion. Imaging studies like X-rays may be utilized to assess joint damage or inflammation. Laboratory tests, including blood tests for markers of inflammation (such as ESR or CRP), and antinuclear antibody (ANA) testing, can support the diagnosis. It is essential to rule out other joint conditions that could present with similar symptoms.

Treatment Protocols: Management of pauciarticular juvenile rheumatoid arthritis affecting the wrist generally aims to reduce inflammation, relieve pain, maintain joint function, and prevent joint damage. Treatments may include: - **Nonsteroidal anti-inflammatory drugs (NSAIDs):** To control pain and inflammation. - **Physical therapy:** To improve joint mobility, strengthen surrounding muscles, and preserve function. - **Disease-modifying antirheumatic drugs (DMARDs):** Such as methotrexate, used in more persistent cases. - **Intra-articular corticosteroid injections:** To directly reduce inflammation in the wrist joint. - **Regular monitoring:** To assess disease progression and adjust therapies accordingly. In some cases, surgical intervention might be considered if joint damage becomes severe or if conservative measures are insufficient. Collaborative care involving rheumatologists, pediatricians, and physical therapists plays a crucial role in managing the condition effectively.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.43 a billable ICD-10 code?
Yes, M08.43 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.43?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, wrist and any associated comorbidities for accurate reporting.

Cite this Clinical Reference